UiPath Inc. (NYSE:PATH - Get Free Report) was down 1.9% during mid-day trading on Friday . The company traded as low as $20.83 and last traded at $20.91. Approximately 1,477,355 shares traded hands during trading, a decline of 84% from the average daily volume of 9,013,123 shares. The stock had previously closed at $21.31.
Analyst Ratings Changes
Several equities analysts have issued reports on PATH shares. Evercore ISI increased their price objective on shares of UiPath from $24.00 to $27.00 and gave the company an "in-line" rating in a report on Thursday, March 14th. Scotiabank increased their price objective on shares of UiPath from $29.00 to $30.00 and gave the company a "sector perform" rating in a report on Thursday, March 14th. BMO Capital Markets increased their price objective on shares of UiPath from $24.00 to $28.00 and gave the company a "market perform" rating in a report on Thursday, March 14th. KeyCorp started coverage on shares of UiPath in a report on Monday. They set an "overweight" rating and a $27.00 price objective on the stock. Finally, Morgan Stanley increased their price objective on shares of UiPath from $17.00 to $25.00 and gave the company an "equal weight" rating in a report on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat, UiPath currently has a consensus rating of "Moderate Buy" and an average price target of $27.41.
View Our Latest Research Report on UiPath
Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon.In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! UiPath Stock Down 2.9 %
The stock has a market capitalization of $11.78 billion, a price-to-earnings ratio of -122.99 and a beta of 0.96. The company's 50-day moving average is $23.35 and its 200-day moving average is $21.33.
UiPath (NYSE:PATH - Get Free Report) last released its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The firm had revenue of $405.25 million during the quarter, compared to analysts' expectations of $383.32 million. Sell-side analysts anticipate that UiPath Inc. will post -0.04 EPS for the current year.
Insider Buying and Selling
In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.66, for a total transaction of $866,400.00. Following the completion of the transaction, the chief financial officer now owns 660,762 shares of the company's stock, valued at $14,312,104.92. The sale was disclosed in a legal filing with the SEC, which is available at this link. Over the last ninety days, insiders sold 72,000 shares of company stock worth $1,591,360. Insiders own 31.03% of the company's stock.
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of PATH. Mark Sheptoff Financial Planning LLC purchased a new position in UiPath during the fourth quarter worth about $25,000. HighMark Wealth Management LLC purchased a new position in UiPath during the fourth quarter worth about $27,000. Tyler Stone Wealth Management purchased a new position in UiPath during the second quarter worth about $28,000. Cypress Capital Management LLC WY purchased a new position in shares of UiPath in the fourth quarter valued at approximately $29,000. Finally, Fifth Third Bancorp grew its holdings in shares of UiPath by 2,005.3% in the third quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company's stock valued at $34,000 after purchasing an additional 1,905 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company's stock.
About UiPath
(Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Read More
- Five stocks we like better than UiPath
- Stock Splits, Do They Really Impact Investors?
- You Can Follow BlackRock’s Market View for Your Money
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Breakout Alert: Coinbase's Consolidation Is About To End
- The How And Why of Investing in Oil Stocks
- 3 Key Stocks Helping to Drive the EV Race
→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Should you invest $1,000 in UiPath right now?
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
13 Stocks Institutional Investors Won't Stop Buying
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
FAQs
PATH Stock 12 Month Forecast
Based on 19 Wall Street analysts offering 12 month price targets for UiPath in the last 3 months. The average price target is $27.50 with a high forecast of $30.00 and a low forecast of $24.00. The average price target represents a 32.59% change from the last price of $20.74.
Is PATH a good stock to buy now? ›
The financial health and growth prospects of PATH, demonstrate its potential to underperform the market. It currently has a Growth Score of A. Recent price changes and earnings estimate revisions indicate this stock lacks momentum and would be a lackluster choice for momentum investors.
What is the outlook for UiPath stock? ›
Based on short-term price targets offered by 17 analysts, the average price target for UiPath comes to $27.29. The forecasts range from a low of $24.00 to a high of $32.00. The average price target represents an increase of 31.58% from the last closing price of $20.74.
What will UiPath stock be worth in 5 years? ›
UiPath stock price stood at $20.74
According to the latest long-term forecast, UiPath price will hit $25 by the end of 2025 and then $30 by the middle of 2027. UiPath will rise to $35 within the year of 2028, $40 in 2029, $45 in 2030, $50 in 2033 and $55 in 2035.
Who are the largest shareholders of UiPath stock? ›
Largest shareholders include Vanguard Group Inc, ARK Investment Management LLC, BlackRock Inc., ARKK - ARK Innovation ETF, Fmr Llc, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, NAESX - Vanguard Small-Cap Index Fund Investor ...
What is the forecast for UiPath in 2024? ›
According to our current PATH stock forecast, the value of UiPath Inc. shares will rise by 11.74% and reach $ 22.79 per share by May 19, 2024.
What is the 12 month forecast for UiPath stock? ›
UiPath Stock Forecast
The 16 analysts with 12-month price forecasts for UiPath stock have an average target of 27.38, with a low estimate of 23 and a high estimate of 32. The average target predicts an increase of 33.37% from the current stock price of 20.53.
Why is PATH stock down? ›
UiPath (PATH) shares gave up early gains and sank over 6% in intraday trading Thursday as the artificial intelligence (AI) software provider and Google partner's weaker-than-expected guidance offset strong results.
What penny stocks to buy today? ›
Penny Stocks To Buy Today
| Company Name | LTP | % Change |
|---|
| Kanani Industries | 3.55 | -4.05 |
| Dynamic Cables Ltd | 557.9 | -3.64 |
| Hilton Metal Forging | 121 | 0.29 |
| Alok Industries | 26.75 | -0.56 |
1 more rowBy automating repetitive tasks, UiPath empowers businesses to unlock a new era of efficiency and productivity. As AI and machine learning continue to evolve, UiPath's capabilities will further expand, paving the way for a future of human-robot collaboration.
Check out UiPath, Inc. revenue and earnings and make informed decisions. What is PATH price target? According to analysts, PATH price target is 27.98 USD with a max estimate of 32.00 USD and a min estimate of 24.00 USD.
What is the future of UiPath company? ›
Fortune Business Insights believes the RPA market could still show a CAGR of 20% from 2023 to 2030. If UiPath keeps pace with that market, its annual revenue could hit $7.2 billion by 2030.
Who is investing in UiPath? ›
Top Institutional Holders
| Holder | Shares | Date Reported |
|---|
| Vanguard Group Inc | 38.08M | Dec 31, 2023 |
| ARK Investment Management, LLC | 31.63M | Mar 31, 2024 |
| Blackrock Inc. | 25.12M | Dec 31, 2023 |
| FMR, LLC | 19.34M | Dec 31, 2023 |
6 more rowsOne thing we'd like to point out is that UiPath has no debt on its balance sheet, which is quite unusual for a cash-burning growth company, which typically has high debt relative to its equity. This means that the company has been operating purely on its equity investment and has no debt burden.
Who invested in UiPath? ›
Funding round led by CapitalG and Sequoia Capital. Series D round of funding led by hedge fund Coatue Management, with participation from Alphabet's CapitalG, Sequoia, Accel, Madrona Venture Group, IVP, Dragoneer, Wellington, Sands Capital, and funds advised by T. Rowe Price & Associates. $10.2 Billion.
What is the 12-month forecast for UiPath stock? ›
UiPath Stock Forecast
The 16 analysts with 12-month price forecasts for UiPath stock have an average target of 27.38, with a low estimate of 23 and a high estimate of 32. The average target predicts an increase of 33.37% from the current stock price of 20.53.
What is the route price prediction 2025? ›
Long-term Router Protocol price prediction for 2025, 2026, 2027, 2028, 2029 and 2030
| Year | Yearly Low | Yearly High |
|---|
| 2025 | $ 3.06 | $ 14.67 |
| 2026 | $ 2.55 | $ 8.22 |
| 2027 | $ 2.80 | $ 5.78 |
| 2028 | $ 4.15 | $ 9.87 |
2 more rowsNASDAQ: CMPS
The lofty target is closer to being within reach than it may seem at first. Per the consensus of Wall Street analysts, Compass Pathways (CMPS 1.35%) stock is on track for an absolutely stellar 12 months. They see its shares rising by 307% compared to where it is today.
Who are the top 10 owners of path stock? ›
Largest shareholders include Vanguard Group Inc, ARK Investment Management LLC, BlackRock Inc., Fmr Llc, ARKK - ARK Innovation ETF, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, NAESX - Vanguard Small-Cap Index Fund Investor ...
UiPath Inc. (NYSE:PATH - Get Free Report) was down 1.9% during mid-day trading on Friday . The company traded as low as $20.83 and last traded at $20.91. Approximately 1,477,355 shares traded hands during trading, a decline of 84% from the average daily volume of 9,013,123 shares. The stock had previously closed at $21.31.
